Header cover image

Brazilian (BOVESPA) Healthcare Sector Analysis

UpdatedJul 15, 2025
DataAggregated Company Financials
Companies16
  • 7D-2.9%
  • 3M10.2%
  • 1Y-10.0%
  • YTD24.3%

Over the last 7 days, the Healthcare industry has dropped 4.1%, driven by Rede D'Or São Luiz declining 2.7%. Meanwhile, Alliança Saúde e Participações actually outperformed within the industry, gaining 16% in the last week. However, the industry is down 9.4% over the past year. Looking forward, earnings are forecast to grow by 30% annually.

Sector Valuation and Performance

Has the Brazilian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 15 Jul 2025R$134.2bR$149.5bR$2.0b11x65.8x0.9x
Thu, 12 Jun 2025R$141.4bR$149.5bR$2.0b10.6x69.4x0.9x
Sat, 10 May 2025R$133.3bR$149.0bR$2.2b10.7x61.3x0.9x
Mon, 07 Apr 2025R$118.7bR$150.7bR$3.6b10.3x33.2x0.8x
Wed, 05 Mar 2025R$115.0bR$146.8bR$4.7b10.7x24.5x0.8x
Fri, 31 Jan 2025R$114.1bR$146.7bR$4.7b11.5x24.4x0.8x
Sun, 29 Dec 2024R$109.7bR$146.7bR$4.7b11.5x23.5x0.7x
Tue, 26 Nov 2024R$128.2bR$148.2bR$5.2b13.7x24.4x0.9x
Thu, 24 Oct 2024R$141.9bR$144.9bR$4.4b11.3x32.2x1x
Sat, 21 Sep 2024R$153.7bR$144.9bR$4.4b11.2x34.9x1.1x
Mon, 19 Aug 2024R$153.8bR$144.8bR$4.3b11.9x35.9x1.1x
Wed, 17 Jul 2024R$148.7bR$143.3bR$4.2b11.9x35.7x1x
Fri, 14 Jun 2024R$137.0bR$142.9bR$4.2b11.3x32.7x1x
Sun, 12 May 2024R$150.4bR$142.3bR$3.8b12.3x39.5x1.1x
Tue, 09 Apr 2024R$141.3bR$140.0bR$3.2b12.5x44.6x1x
Thu, 07 Mar 2024R$143.4bR$132.9bR$2.7b14.6x52.8x1.1x
Sat, 03 Feb 2024R$150.7bR$135.0bR$2.9b16.7x52.3x1.1x
Mon, 01 Jan 2024R$169.9bR$135.0bR$2.9b21.2x58.9x1.3x
Wed, 29 Nov 2023R$160.1bR$135.0bR$2.9b19.4x55.5x1.2x
Fri, 27 Oct 2023R$144.6bR$126.1bR$2.7b18.3x52.6x1.1x
Sun, 24 Sep 2023R$162.1bR$126.1bR$2.7b19.5x59x1.3x
Tue, 22 Aug 2023R$177.8bR$126.1bR$2.7b20.2x64.7x1.4x
Thu, 20 Jul 2023R$183.5bR$116.7bR$2.8b16.5x65.1x1.6x
Sat, 17 Jun 2023R$182.9bR$116.7bR$2.8b16.9x64.6x1.6x
Mon, 15 May 2023R$148.4bR$108.1bR$2.9b17.4x50.3x1.4x
Wed, 12 Apr 2023R$136.6bR$106.3bR$3.3b14.6x41.1x1.3x
Fri, 10 Mar 2023R$138.0bR$102.8bR$3.8b14.7x36.5x1.3x
Sun, 05 Feb 2023R$173.6bR$98.3bR$4.2b15.5x41.6x1.8x
Tue, 03 Jan 2023R$163.7bR$98.3bR$4.2b15x39.3x1.7x
Thu, 01 Dec 2022R$170.4bR$98.3bR$4.2b16.1x40.9x1.7x
Sat, 29 Oct 2022R$191.4bR$90.4bR$4.6b16.8x41.6x2.1x
Mon, 26 Sep 2022R$207.7bR$90.4bR$4.6b16.7x45.2x2.3x
Wed, 24 Aug 2022R$198.7bR$90.2bR$4.5b14x44.4x2.2x
Fri, 22 Jul 2022R$176.5bR$84.2bR$5.2b13.1x33.7x2.1x
Price to Earnings Ratio

33.7x


Total Market Cap: R$176.5bTotal Earnings: R$5.2bTotal Revenue: R$84.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Healthcare Sector Price to Earnings3Y Average 45x202320242025
Current Industry PE
  • Investors are optimistic on the Brazilian Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 65.5x which is higher than its 3-year average PE of 45.0x.
  • The 3-year average PS ratio of 1.3x is higher than the industry's current PS ratio of 0.89x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 27% per year over the last three years.
  • Meanwhile revenues for these companies have grown 21% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Brazilian Healthcare sector?

BR Market-2.93%
Healthcare-2.89%
Medical Equipment-0.062%
Biotech-1.06%
Pharma-2.46%
Healthcare Services-3.02%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 97.2x.
    • Analysts are expecting annual earnings growth of 29.7%, which is lower than the prior year's growth of 43.2% per year.
  • Investors are most pessimistic about the Medical Equipment industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 32% over the next 5 years.
  • This is better than its past earnings decline of 52% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 8.6% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AALR3 Alliança Saúde e ParticipaçõesR$5.2112.0%
+R$66.2m
-58.2%PS0.5x
ODPV3 OdontoprevR$11.340.4%
+R$27.3m
-7.0%PE11x
PFRM3 Profarma Distribuidora de Produtos FarmacêuticosR$8.241.9%
+R$18.4m
55.5%PE8.1x
BLAU3 Blau FarmacêuticaR$12.980.2%
+R$5.3m
5.6%PE8.6x
MATD3 Hospital Mater DeiR$4.480.2%
+R$3.4m
-7.2%PS0.7x

Latest News